BioCentury
ARTICLE | Company News

North American Bio, Univax deal

December 4, 1995 8:00 AM UTC

The shareholders of each company approved the merger of the companies in a tax-free, stock-for-stock transaction (see BioCentury Sept. 5). UNVX shareholders are entitled to 0.79 shares of NBIO common stock in exchange for each UNVX share.

David Gury will remain NBIO chairman, president and CEO, while Thomas Stagnaro, UNVX president and CEO, will serve as senior executive vice president. Sales, marketing and administration will be consolidated at Boca Raton, while R&D will be headquartered in Rockville. ...